Table 1 Patient demographics and characteristics of the flaps
From: Treatment of deep cavities using a perforator-based island flap with partial de-epithelization
No. | Age range (years) | Defect | Size, (cm2) | Depth of cavity (cm) | Size of de-epithelization (cm2) | Perforator | Follow-up (months) | Complication |
|---|---|---|---|---|---|---|---|---|
1 | 70–79 | Sacral sore | 10 × 6 | 3 | 6 × 3 | SGAP | 25 | None |
2 | 80–89 | Sacral sore | 17 × 10 | 5 | 10 × 5 | SGAP | 20 | None |
3 | 60–69 | Ischial sore | 8 × 5 | 2 | 5 × 2 | DFP | 18 | None |
4 | 50–59 | Meningomyelocele | 10 × 4 | 4 | 5 × 4 | SGAP | 18 | None |
5 | 60–69 | Sacral sore | 15 × 13 | 3 | 10 × 3 | SGAP | 18 | None |
6 | 80–89 | Sacral sore | 11 × 7 | 4 | 6 × 4 | IGAP | 17 | None |
7 | 70–79 | Ischial sore | 12 × 10 | 3 | 8 × 3 | DFP | 15 | None |
8 | 60–69 | Sacral sore | 12 × 10 | 4 | 10 × 4 | SGAP | 15 | None |
9 | 50–59 | Meningomyelocele | 7 × 3 | 4 | 4 × 3 | SGAP | 15 | None |
10 | 30–39 | Cutaneous fistula | 4 × 4 | 9 | 9 × 4 | DIEP | 13 | Congestion |
11 | 30–39 | Sacral sore | 10 × 10 | 2 | 10 × 2 | SGAP | 13 | None |
12 | 30–39 | Cutaneous fistula | 4 × 4 | 9 | 9 × 4 | DIEP | 13 | Partial necrosis |
13 | 60–69 | Trochanter sore | 9 × 7 | 3 | 7 × 3 | TFLP | 13 | None |
14 | 50–59 | Sacral sore | 9 × 5 | 3 | 5 × 3 | IGAP | 13 | None |
15 | 60–69 | Sacral sore | 10 × 11 | 4 | 8 × 4 | SGAP | 12 | None |
16 | 40–49 | Sacral sore | 4 × 2 | 3 | 3 × 2 | IGAP | 12 | None |
17 | 40–49 | Ischial sore | 12 × 6 | 4 | 6 × 4 | DFP | 12 | None |
18 | 70–79 | Cutaneous fistula | 3 × 4 | 4 | 4 × 4 | DIEP | 10 | None |
19 | 80–89 | Trochanter sore | 8 × 6 | 2 | 6 × 2 | TFLP | 10 | None |
20 | 80–89 | Trochanter sore | 6 × 5 | 1 | 4 × 1 | TFLP | 10 | None |
21 | 60–69 | Sacral | 15 × 8 | 4 | 8 × 4 | SGAP | 7 | None |